On February 21, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. approved the following appointments to its Board committees: (i) Audit Committee Jeff Keyes (Chair), Carl Evans and Amy Mahery; (ii) Compensation Committee Dr. Jerzy (George) Gumulka (Chair), Jeff Keyes and Dr. Bettina Cockroft; and (iii) Nominating and Governance Committee Dr. Bettina Cockroft (Chair) and Faith Charles.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 USD | +10.60% | +13.53% | -81.10% |
04-30 | Transcript : CNS Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
04-23 | Transcript : CNS Pharmaceuticals, Inc. - Special Call |
1st Jan change | Capi. | |
---|---|---|
-81.10% | 2.31M | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- CNSP Stock
- News CNS Pharmaceuticals, Inc.
- CNS Pharmaceuticals, Inc. Approves the Appointments to its Board Committees